Related Experiment Video
Updated: Feb 1, 2026
07:25
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.8K
Amputation for osteomyelitis in a patient with spina bifida
Karen K M Chui1, Jeremy Newman1, Simon D Hobbs1
1Black Country Vascular Unit, The Dudley Group NHS Foundation Trust, Dudley, UK.
Journal of Surgical Case Reports
|December 4, 2018
Summary
Osteomyelitis in patients with spina bifida presents unique challenges. Early surgical amputation and multidisciplinary care can improve outcomes for this patient population.
Area of Science:
- Vascular Surgery
- Orthopedic Surgery
- Pediatric Surgery
Background:
- Spina bifida is a complex congenital condition often leading to chronic health issues.
- Osteomyelitis, a bone infection, poses significant challenges in patients with spina bifida due to underlying anatomical and physiological factors.
Observation:
- A case of osteomyelitis in a patient with spina bifida was managed by a vascular surgeon.
- The case highlighted the intricate difficulties in diagnosing and treating bone infections in this specific demographic.
Findings:
- Review of existing literature on osteomyelitis in spina bifida patients.
- Demonstration of the benefits of a coordinated, multidisciplinary approach to patient care.
- Emphasis on the potential advantages of early surgical amputation as a treatment option.
Implications:
- Highlights the need for specialized, integrated care pathways for spina bifida patients with osteomyelitis.
- Suggests that prompt surgical intervention, including amputation, may be a crucial factor in successful management.
- Informs vascular and orthopedic surgeons about optimizing treatment strategies for this vulnerable patient group.
Related Concept Videos
01:13Patient-centered Care
3.0K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
01:15Drug Dosing: Geriatric Patients
274
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
274
01:21Drug Dosing: Obese Patients
266
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
266
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
236
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
236
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
261
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
307
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
307